Efficacy and cost-effectiveness of new oral anticoagulants compared to Warfarin for the prevention of stroke in patients with atrial fibrillation /
Warfarin has been used as the only oral anticoagulant for over 50 years in patients with atrial fibrillation. Recently new oral anticoagulants like dabigatran, rivaroxaban and apixaban have been developed for this indication. We compared these new oral anticoagulants with each other and with warfari...
| Main Authors: | , , , , |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
Oslo :
Norwegian Knowledge Centre for the Health Services,
March 2013
|
| Series: | Rapport fra Kunnskapssenteret ;
no. 5-2013 |
| Subjects: |